Discover the techniques that help popular scripts succeed.
In an interview with Vanity Fair, R.J. Cipriani is eager to share his side of an alleged extortion saga that has ensnared studio executive Jeff Shell.
Novartis' acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company's existing allergy portfolio. It comes just a week after Novartis announced it is acquiring ...
Commercial vessels are deploying high-tech sensors to map a shifting sea, providing critical data for scientists and some help for the industry. By Eric Niiler and Tristan Spinski The panel voted to ...